BioWorld MedTech

April 18, 2016

Vertos prods CMS for another look at national coverage decision of PILD

Vertos Medical Inc. has requested that the CMS reopen a national coverage decision after only two years, a move that could open the procedure up to millions of Medicare beneficiaries in the years ahead. Read More

Illumina commits $100M to new VC firm founded by former company exec

SEM Scanner set to ease the pressure in the Canadian wound care market

Elekta bets future on game-changer in radiotherapy

Other News to Note

Daily M&A

Financings

Regulatory Front

Keeping you up to date on recent developments in neurology

Today's news in brief

BioWorld

BioWorld briefs for Dec. 16, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 16, 2025.

Illustration of tau accumulating in a neuron cell.

ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug

BioWorld

ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...

Businesspeople shaking hands, meeting with cityscape, charts

Deals and an M&A strengthen end-of-year numbers

BioWorld

Two large deals and an acquisition, totaling about $4.64 billion in all, are helping wrap up what’s turning out to be a strong year. Through the first 11 months...

Neutrophils put the brakes on fat loss

BioWorld Science

Fat tissue balances energy by storing lipids during times of abundance and mobilizing them when needed, yet sustained metabolic stress demands mechanisms that...